NCT03528538

Brief Summary

  1. 1.The problem: There is limited research on the use of herbal supplements in general, and fenugreek specifically, to improve male health, particularly to increase testosterone levels. As well, no located studies have examined the effects of fenugreek supplementation on healthy men's health-related quality of life, anxiety levels, and body composition.
  2. 2.Relevant research examined the effects of fenugreek supplementation with healthy men aged between 43 and 70 years of age. The researchers found that both total serum testosterone and free testosterone increased compared to placebo after 12 weeks of active treatment. The researchers concluded that fenugreek supplementation was a safe and effective treatment for reducing symptoms of possible androgen deficiency, improves sexual function and increases serum testosterone in healthy middle-aged to older men. Another study found that fenugreek supplementation improved aging male symptoms and testosterone levels remained in a normal range in healthy men aged 25 to 45 years.
  3. 3.The importance of this study: The importance of this study is to help determine if fenugreek supplementation affects testosterone levels, body composition, health-related quality of life, anxiety, and aging symptoms in healthy men aged 21 - 45 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 19, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 18, 2018

Completed
Last Updated

May 18, 2018

Status Verified

May 1, 2018

Enrollment Period

3 months

First QC Date

February 26, 2018

Last Update Submit

May 16, 2018

Conditions

Keywords

FenugreekAging Male SymptomsTestosteroneSupplementationDouble BlindBody Composition

Outcome Measures

Primary Outcomes (5)

  • Health Related Quality of Life Questionnaire

    The Centers for Disease Control (CDC) Health-related Quality of Life measure will be used to assess health-related quality of life. This scale has excellent psychometric properties. The HRQoL assesses the positive and negative aspects of a person's life such as satisfaction or distress and the impact of these factors to their perceived health and life experience. This questionnaire is a valid and reliable measure than can be used to evaluate the individuals physical and mental perceptions.

    8 weeks

  • Aging Male Symptoms Questionnaire

    The Aging Male Questionnaire consists of 17 questions in 3 sub-scales (i.e., psychological, somatic and sexual) that assesses symptoms of aging specific for men. These sub-scales as well as the total score were used to assess symptoms. Having symptoms from the AMS questionnaire merely suggests a male may have deficiencies but blood samples are the best determinants of this condition. The higher the score, the worst the outcome.

    8 weeks

  • Blood

    From 10 mL of fasted blood. The free testosterone, total testosterone, and estradiol levels will be extracted from the blood sample.

    8 weeks

  • Body Composition

    The BODPOD machine is considered the gold standard for body composition as it has a range of error between ± 1 to 2.7% and is easier to complete than underwater weighing. The BODPOD was used to observe body composition at each assessment

    8 weeks

  • Strength

    Hand grip dynamometer

    9 weeks

Study Arms (3)

Placebo

PLACEBO COMPARATOR
Other: Placebo

AlphaFen fenugreek 400 mg

ACTIVE COMPARATOR

This group received 400 mg of fenugreek to be ingested daily for 60 days.

Dietary Supplement: AlphaFen fenugreek 400 mg

AlphaFen fenugreek 500 mg

ACTIVE COMPARATOR

This group received 500 mg of fenugreek to be ingested daily.

Dietary Supplement: AlphaFen fenugreek 500 mg

Interventions

AlphaFen fenugreek 400 mgDIETARY_SUPPLEMENT

A brand of fenugreek supplementation that was produced by SPECNOVA. Pure fenugreek without any additives.

AlphaFen fenugreek 400 mg
AlphaFen fenugreek 500 mgDIETARY_SUPPLEMENT

A brand of fenugreek supplementation that was produced by SPECNOVA. Pure fenugreek without any additives.

AlphaFen fenugreek 500 mg
PlaceboOTHER

rice flour in a vegetable/ cellulose capsule

Placebo

Eligibility Criteria

Age21 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men between the ages of 21- 45 that were recreationally active.

You may not qualify if:

  • Above 30% body composition, not in the age range, history of asthma, diabetes, hypoglycemia, or took any hormonal supplements such as testosterone or anabolic steroids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jacksonville University

Jacksonville, Florida, 32211, United States

Location

Related Publications (9)

  • Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, Saad F, Potthoff P, Thai do M. The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes. 2003 Dec 15;1:77. doi: 10.1186/1477-7525-1-77.

    PMID: 14675485BACKGROUND
  • Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc. 1995 Dec;27(12):1692-7.

    PMID: 8614327BACKGROUND
  • Fess, E. E. (1992). Grip strength. In clinical assessment recommendations. 2nd ed. Chicago: American Society of Hand Therapists.

    BACKGROUND
  • Rao A, Steels E, Inder WJ, Abraham S, Vitetta L. Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. Aging Male. 2016 Jun;19(2):134-42. doi: 10.3109/13685538.2015.1135323. Epub 2016 Jan 20.

    PMID: 26791805BACKGROUND
  • Spielberger, CD., Gorsuch, R.L., Lushene, R., Vagg, P.R., & Jacobs, G.A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.

    BACKGROUND
  • Steels E, Rao A, Vitetta L. Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation. Phytother Res. 2011 Sep;25(9):1294-300. doi: 10.1002/ptr.3360. Epub 2011 Feb 10.

    PMID: 21312304BACKGROUND
  • Wankhede S, Mohan V, Thakurdesai P. Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: A randomized controlled pilot study. J Sport Health Sci. 2016 Jun;5(2):176-182. doi: 10.1016/j.jshs.2014.09.005. Epub 2015 Mar 7.

    PMID: 30356905BACKGROUND
  • Zack MM; Centers for Disease Control and Prevention (CDC). Health-related quality of life - United States, 2006 and 2010. MMWR Suppl. 2013 Nov 22;62(3):105-11.

    PMID: 24264499BACKGROUND
  • Hausenblas HA, Conway KL, Coyle KRM, Barton E, Smith LD, Esposito M, Harvey C, Oakes D, Hooper DR. Efficacy of fenugreek seed extract on men's psychological and physical health: a randomized placebo-controlled double-blind clinical trial. J Complement Integr Med. 2020 May 22;18(2):445-448. doi: 10.1515/jcim-2019-0101.

Study Officials

  • Heather Hausenblaus, PhD

    Jacksonville University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The investigators and the participants remained blind until after the total completion of the experiment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects will complete 3 assessments during the study at Day 0, Week 4, and Week 8. At each assessment, they complete the following: self-report inventories (e.g., Aging Male Symptoms Questionnaire, Trait Anxiety Inventory, Health-related Quality of Life), body composition via BOD POD, heart rate, blood pressure, and blood draws. The subjects will be randomized to one of the following three conditions: (1) AlphaFenTM fenugreek (400 mg/d), (2) AlphaFenTM fenugreek (500 mg/d), or (2) placebo control. The subjects will be asked to take one capsule of the fenugreek supplement or placebo daily for eight weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2018

First Posted

May 18, 2018

Study Start

September 19, 2017

Primary Completion

December 15, 2017

Study Completion

December 15, 2017

Last Updated

May 18, 2018

Record last verified: 2018-05

Locations